SAMUEL HOFFMAN: Open Payments
NPI 1669831871 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$685 in 26 payments from 7 companies in 2025. Trend: 2023 $103 · 2024 $0 · 2025 $685
Food & beverage: $685
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $187 |
| Gilead Sciences, Inc. | 3 | $159 |
| Otsuka America Pharmaceutical, Inc. | 7 | $157 |
| PFIZER INC. | 3 | $76 |
| Alkermes, Inc. | 3 | $72 |
| Janssen Pharmaceuticals, Inc | 1 | $19 |
| Hologic Sales and Service, LLC | 1 | $16 |
Products named: VRAYLAR, REXULTI, Biktarvy, ARISTADA, ELIQUIS, UBRELVY, NURTEC ODT, QULIPTA.
Industry payments across PA — which companies pay providers there.
